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Fig. 2. Temporal profile of NITEGE fragment in Guinea Pig synovial fluid lavage.
Data represents mean ± Standard error of the mean.
a function of age and disease progression (p<0.045 at 3 and 6
months), with the medial cartilage levels being greater than the
corresponding lateral compartment (Figure 1).
A similar time-dependant increase in aggrecanase-generated
fragments was observed in synovial fluid lavages from selected
groups of the same animals (Figure 2). These increased levels
of neo-epitope correlate with degenerative changes occurring
within the cartilage extracellular matrix.
Conclusions: The Dunkin Hartley guinea pig displays a spon-
taneous onset of progressive degenerative changes that closely
resemble the development of osteoarthritis in humans. Earliest
histological signs are observed in the medial tibial compart-
ment at 3 months of age with moderate and severe degenerative
changes at one year old (1). In this study aggrecanase-generated
neo-epitope was present in medial tibial cartilage at 3 and 4
months of age and appeared to precede cartilage destruction,
levels were maximum at 6 months at typical on-set of disease
and these levels were maintained as the disease progressed.
This is similar to human arthritis where aggrecan neo-epitope
fragments have been shown to increase with disease in hu-
man arthritic synovial fluids (2). This study thus reinforces the
relevance of the guinea pig model for testing chondroprotective
drugs and their potential role relative to disease state and activity
in disease modification in OA.
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Purpose: We evaluated the changes in peri-articular bone in two
canine models of osteoarthritis: the groove model, in which the
articular cartilage of the femoral condyles is surgically damaged,
and the ACLT model.
Methods: Tibial plateaus were evaluated at 10 and 20 weeks
post-surgery for the groove and ACLT model and also at 3
weeks for the groove model. Cartilage integrity was analysed
and architecture of subchondral plate and trabecular bone of
epiphyses was quantified using micro-CT.
Results: Cartilage histology/biochemistry demonstrated the
characteristic features of osteoarthritis for the groove model at 10
and 20 weeks (no changes at 3 weeks) and the ACLT model. The
groove model presented osteophytes only at 20 weeks, whereas
the ACLT showed osteophytes already at 10 weeks.
Trabecular bone volume fraction (BV/TV) and trabecular thick-
ness in the groove model showed a slight increase at 3 and
10 weeks (+6%), to a slight decrease at 20 weeks (-4%). This
contrasts the ACLT model in which BV/TV was clearly reduced
at 10 and 20 weeks (15-20%). In contrast, the changes in the
subchondral plate were very consistent in both models at all
time points. For both models the subchondral plate thickness
drastically reduced (25-40%) in all animals and plate porosity
increased (25-85%) in all animals, already clearly detectable at
3 weeks in the groove model.
Conclusions: These findings indicate differential regulation of
subchondral trabecular bone in the groove and ACLT model.
The changes in the subchondral plate were similar in both
models. The very early changes in plate thickness and porosity
in the groove model (after 3 weeks), in the absence of cartilage
changes, demonstrates that bone changes precede cartilage
changes and may implicate an etiological role for subchondral
bone in the onset of osteoarthritis.
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Purpose: Intra-articular injection of hyaluronan preparations is
commonly utilized in the treatment of osteoarthritis (OA), how-
ever, it often required 3-5 administrations to achieve efficacy.
Gel-200 is a newly developed cross-linked hyaluronate hydrogel
as a novel therapeutic agent for the knee OA. The objective of
this study was to examine the efficacy of Gel-200 in the rabbit
ACL transection model. The ACL transection model used in this
study has been accepted as an arthritis model, which produces
cartilage degradation similar to OA in humans.
Methods: Experimental OA was induced in 48 male rabbits by
transecting the unilateral ACL. Four weeks after the ACL transec-
tion, Gel-200 was administered once or twice (at an interval of 2
weeks) into the joint cavity of the left hind knee at a dose of 0.05
mL/kg/joint. Its efficacy was compared to that of repeated ad-
ministration of PBS or SUPARTZ® once a week for 5 weeks. All
animals were sacrificed 9 weeks after ACL transection. The left
knee joints were then removed and evaluated by morphological
assessment of cartilage degeneration, volume of synovial fluid
and protein content, number of infiltrated cells and glycosamino-
glycans content in synovial fluid as indicators of synovitis, and
histopathological examination of the cartilage and synovium.
Results: In the morphological assessment, cartilage degenera-
tion was less in the Gel-200 groups compared to the SUPARTZ®.
In fact, in both the one- and two-injections Gel-200 groups the
degeneration of the articular cartilage was significantly less com-
pared with control treated with 5-weekly injections of PBS. In
contrast, SUPARTZ® administration decreased the cartilage de-
generation compared with control, but the efficacy was not sig-
nificant. The severity comparison among the test substances
